noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

Pharmaceuticals and Biotechnology

Advicenne SA

3 novembre 2026 Information mensuelle relative au nombre total de[...]
ANSM - French Agency for the[...]

Caelyx Pegylated Liposomal 2 mg/ml, solution à diluer pour perfusion :[...]
Kairos Pharma Ltd.

Material Agreement (Form 8-K)

Economy, Business and Finance

Exozymes Inc.

11/03/2026 | Press release | Distributed by Public on 11/03/2026 10:33

Tomorrow Today show: AI, enzymes and the future of medicine

November 3, 2026-

heltzennutraceuticalsmedicinepress clippingsvideopodcastNCT

Tomorrow Today show: AI, enzymes and the future of medicine

AI is already transforming how we work, think, and innovate. But what happens when we combine its power with biology itself?

In a fascinating conversation on Tomorrow Today, eXoZymes CEO Michael Heltzen joins host Shekhar Natarajan to explore a future where biology becomes programmable, medicines are reimagined, and scientific breakthroughs move from the lab into the real world.

From AI and digital biology to entrepreneurship and the future of human ingenuity, this conversation goes well beyond biotechnology - watch the full podcast episode here

Exozymes Inc. published this content on November 03, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 03, 2026 at 16:33 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]

Back

View original format